Total Payments
$1,886
2024 Payments
$988.96
Companies
18
Transactions
98
Medicare Patients
508
Medicare Billing
$51,201
Payment Breakdown by Category
Food & Beverage$1,886 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,886 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $630.68 | 33 | $0 (2024) |
| Lilly USA, LLC | $282.87 | 14 | $0 (2024) |
| Exact Sciences Corporation | $153.82 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $137.91 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $121.45 | 8 | $0 (2024) |
| ABBVIE INC. | $99.43 | 5 | $0 (2024) |
| Novo Nordisk Inc | $88.00 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $64.11 | 4 | $0 (2022) |
| Amgen Inc. | $55.34 | 2 | $0 (2024) |
| Eisai Inc. | $39.92 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $988.96 | 50 | GlaxoSmithKline, LLC. ($276.84) |
| 2023 | $417.09 | 22 | GlaxoSmithKline, LLC. ($199.26) |
| 2022 | $233.05 | 13 | GlaxoSmithKline, LLC. ($106.64) |
| 2021 | $246.72 | 13 | GlaxoSmithKline, LLC. ($47.94) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 4 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Gastroenterology | ||||||
| 09/08/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Diabetes | ||||||
| 08/04/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Gastroenterology | ||||||
| 06/08/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Gastroenterology | ||||||
| 02/10/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 12/15/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Diabetes | ||||||
| 12/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardiovascular | ||||||
| 09/03/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Sleep | ||||||
| 07/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Central Nervous System | ||||||
| 05/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Diabetes | ||||||
| 02/24/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 163 | 177 | $48,580 | $16,568 |
| 2022 | 6 | 119 | 165 | $41,765 | $13,393 |
| 2021 | 6 | 123 | 159 | $37,680 | $12,132 |
| 2020 | 4 | 103 | 152 | $32,240 | $9,109 |
Total Patients
508
Total Services
653
Medicare Billing
$51,201
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 57 | $19,950 | $7,020 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 52 | $8,580 | $3,228 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $7,200 | $2,214 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 22 | $5,500 | $1,934 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $4,550 | $1,294 | 28.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 16 | $2,800 | $877.67 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 36 | $12,600 | $4,456 | 35.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 50 | $8,750 | $2,510 | 28.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $6,750 | $2,282 | 33.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $7,475 | $2,236 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $3,250 | $1,131 | 34.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 28 | $2,940 | $778.12 | 26.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 32 | $11,200 | $3,961 | 35.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 30 | 30 | $9,750 | $2,816 | 28.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,650 | $2,466 | 32.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 32 | $5,600 | $1,669 | 29.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 22 | $2,310 | $612.26 | 26.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 18 | 26 | $1,170 | $609.01 | 52.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 32 | 32 | $10,400 | $3,148 | 30.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 32 | 48 | $8,400 | $2,422 | 28.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 24 | $8,400 | $2,181 | 26.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 18 | 48 | $5,040 | $1,358 | 26.9% |
About Susan Ade, APRN, RN
Susan Ade, APRN, RN is a Gerontology healthcare provider based in Shelton, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447447008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Susan Ade, APRN, RN has received a total of $1,886 in payments from pharmaceutical and medical device companies, with $988.96 received in 2024. These payments were reported across 98 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,886).
As a Medicare-enrolled provider, Ade has provided services to 508 Medicare beneficiaries, totaling 653 services with total Medicare billing of $51,201. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Other Specialties Gerontology
- Location Shelton, CT
- Active Since 09/27/2007
- Last Updated 02/26/2021
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1447447008
Products in Payments
- TRELEGY ELLIPTA (Drug) $588.97
- Cologuard Collection Kit (Device) $153.82
- JARDIANCE (Drug) $139.15
- XIFAXAN (Drug) $121.45
- AMYVID (Drug) $101.62
- MOUNJARO (Drug) $95.43
- TRINTELLIX (Drug) $64.11
- OFEV (Drug) $59.28
- VRAYLAR (Drug) $56.84
- EVENITY (Biological) $55.34
- Ozempic (Drug) $49.42
- QULIPTA (Drug) $42.59
- AREXVY (Drug) $41.71
- Leqembi (Drug) $39.92
- FARXIGA (Drug) $39.06
- Vascepa (Drug) $29.45
- TRULICITY (Drug) $25.30
- BELSOMRA (Drug) $24.55
- ACCRUFER (Drug) $24.24
- PREVNAR 20 (Biological) $23.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.